Please login to the form below

Not currently logged in
Email:
Password:

Roche's Chugai recalls Vesanoid in Japan

Roche's Japanese subsidiary Chugai has recalled its Vesanoid capsules for acute promyelocytic leukemia in Japan.

Roche's Japanese subsidiary Chugai has recalled its Vesanoid capsules for acute promyelocytic leukemia in Japan.

The recall follows the discovery of bovine-derived material sourced from Canada in a specific batch of the capsules imported from Roche, which is based in Switzerland.

Use of such material requires a partial amendment to the approval document for use in Japan.

Chugai and Roche had agreed not to export Vesanoid capsules using the material to Japan, but went ahead with the exportation anyway because Roche believed that its use was approved in the region.

Vesanoid had annual sales of approximately USD 24m for the twelve months ended April 2007, based on IMS sales data.

3rd August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics